Luyuan Pharmaceutical: Net profit for the first half of 2026 was 143 million yuan, a decrease of 7.46% compared to the same period last year.

Luyan Pharmaceuticals announced that in the first half of 2026, the operating income was 10.583 billion yuan, a year-on-year increase of 1.75%. The net profit attributable to shareholders of the listed company was 143 million yuan, a year-on-year decrease of 7.46%. The net profit excluding non-recurring gains and losses was 138 million yuan, a year-on-year decrease of 9.88%. The company plans not to distribute cash dividends, issue bonus shares, or capitalize its surplus reserves to increase its share capital.